Since most non-biological medicines don't cost very much to manufacture at all; enough profit is enough to cover that drug's R&D and the R&D of the 9 other drugs that didn't pan out. If the US market can cover all those costs, then whatever you get out of other countries is gravy. If that ceases to be true, then other countries will have to pony up more money or go without.